References
M.C. Savanelli, E. Scarano, G. Muscogiuri, L. Barrea, L. Vuolo, M. Rubino, S. Savastano, A. Colao, C. Di Somma, Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D? Endocrine (2015). doi:10.1007/s12020-015-0779-3
P. Ameri, A. Giusti, M. Boschetti, M. Bovio, C. Teti, G. Leoncini, D. Ferone, G. Murialdi, F. Minuto, Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency. Eur. J. Endocrinol. (2013). doi:10.1530/EJE-13-0510
C.A. Nowson, J.J. McGrath, P.R. Ebeling, A. Haikerwal, R.M. Daly, K.M. Sanders, M.J. Seibel, R.S. Mason, Working Group of Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia: vitamin D and health in adults in Australia and New Zealand: a position statement. Med. J. Aust. 196(11), 686–687 (2012)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Rights and permissions
About this article
Cite this article
Purtell, L., Viardot, A. & Campbell, L.V. Vitamin D levels in primary growth hormone deficiency disorder Prader–Willi syndrome. Endocrine 53, 619–620 (2016). https://doi.org/10.1007/s12020-016-0889-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-0889-6